Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Demographic characteristic of participants who took AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Table 1 Expand

Table 2.

The prevalence of side effects among health workers after first dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Table 2 Expand

Fig 1.

The duration of side effects of among health workers after first dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Fig 1 Expand

Table 3.

The prevalence of side effects among health workers after second dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Table 3 Expand

Fig 2.

The duration of side effects of among health workers after second dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Fig 2 Expand

Table 4.

The correlation of participant’s age and side effect after first and second dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Table 4 Expand

Table 5.

The correlation of participant’s sex and side effect after first and second dose of AstraZeneca COVID-19 vaccine from July 01, 2021 to July 30, 2021 in Nigist Eleni Mohammed memorial comprehensive specialized hospital.

More »

Table 5 Expand